126 related articles for article (PubMed ID: 7706525)
1. Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease.
Vallance DT; Staunton HA; Winder AF
J Clin Pathol; 1995 Jan; 48(1):70-4. PubMed ID: 7706525
[TBL] [Abstract][Full Text] [Related]
2. Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.
Sweetnam PM; Bolton CH; Downs LG; Durrington PN; MacKness MI; Elwood PC; Yarnell JW
Eur J Clin Invest; 2000 Nov; 30(11):947-56. PubMed ID: 11114956
[TBL] [Abstract][Full Text] [Related]
3. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) is a potential coronary risk factor.
Fujino A; Watanabe T; Kunii H; Yamaguchi N; Yoshinari K; Watanabe Y; Mutou M; Ishikawa S; Ogyuu A; Ashikawa K; Maruyama Y
Jpn Circ J; 2000 Jan; 64(1):51-6. PubMed ID: 10651207
[TBL] [Abstract][Full Text] [Related]
5. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.
Tilly-Kiesi M; Lichtenstein AH; Joven J; Vilella E; Cheung MC; Carrasco WV; Ordovas JM; Dolnikowski G; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3513-8. PubMed ID: 9437200
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration.
Bigot E; Robert B; Bard JM; Mainard F
Clin Chim Acta; 1997 Sep; 265(1):99-111. PubMed ID: 9352133
[TBL] [Abstract][Full Text] [Related]
7. Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery.
Coste-Burel M; Mainard F; Chivot L; Auget JL; Madec Y
Clin Chem; 1990 Nov; 36(11):1889-91. PubMed ID: 2242564
[TBL] [Abstract][Full Text] [Related]
8. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
Oyelola OO; Ajayi AA; Babalola RO; Stein EA
J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
[TBL] [Abstract][Full Text] [Related]
10. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
12. Apolipoproteins and lipoprotein particles in Moroccan patients with previous myocardial infarction.
Adlouni A; el Messal M; Ghalim N; Saïle R
Int J Clin Lab Res; 1997; 27(4):247-52. PubMed ID: 9506269
[TBL] [Abstract][Full Text] [Related]
13. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
14. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.
Cantin B; Gagnon F; Moorjani S; Després JP; Lamarche B; Lupien PJ; Dagenais GR
J Am Coll Cardiol; 1998 Mar; 31(3):519-25. PubMed ID: 9502629
[TBL] [Abstract][Full Text] [Related]
15. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study).
Luc G; Bard JM; Evans A; Arveiler D; Ruidavets JB; Amouyel P; Ducimetiere P
Atherosclerosis; 2000 Oct; 152(2):399-405. PubMed ID: 10998468
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
[TBL] [Abstract][Full Text] [Related]
17. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(4):368-73. PubMed ID: 22836074
[TBL] [Abstract][Full Text] [Related]
19. ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.
Kido T; Kondo K; Kurata H; Fujiwara Y; Urata T; Itakura H; Yokoyama S
Lipids Health Dis; 2017 Nov; 16(1):225. PubMed ID: 29187200
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study.
Hopkins PN; Hunt SC; Schreiner PJ; Eckfeldt JH; Borecki IB; Ellison CR; Williams RR; Siegmund KD
Atherosclerosis; 1998 Dec; 141(2):333-45. PubMed ID: 9862182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
